Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Location-based method to specify ratio frequency spectrum rights
Optical navigation device with image sensor and inner housing
Electromagnetic probe for measuring properties of a subsurface formation
Fluid conduit with PTC fabric heating
Bootstrap gate driver
Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
Electronic device and printed circuit board
  Randomly Featured Patents
Pinball game with ganged kicker mechanisms
Semiconductor device and method for manufacturing the same
Original reading unit, image forming apparatus and image scanner
Method and apparatus for manufacturing soft metal sheaths for electrical wires
Zoom lens system and camera including the same
Layered resource structure and method
Wireless communications structures and methods utilizing frequency domain spatial processing
Magnetic disc device
Case for electronic device
Process for the heat treatment of thick walled steel pipes